Research

Hormonal

Metformin treatment is associated with reduced cancer risk, potentially through AMPK activation and inhibition of mTOR.

Metformin is associated with reduced cancer risk in diabetic patients, possibly via AMPK/mTOR pathways. This is a potential therapeutic avenue, not a lifestyle recommendation.

GoodSupportsHIGH confidence
recent clinical studies have revealed that treatment with the biguanide metformin, a first-line treatment for patients with type 2 diabetes, is significantly associated with reduced cancer risk
Javier A. Menéndez et al. · Clinical Chemistry · 2009

Why this rating

Cited clinical studies show significant association, but the paper is a review.

Source

Fatty Acid Synthase: Association with Insulin Resistance, Type 2 Diabetes, and Cancer

Javier A. Menéndez et al. · Clinical Chemistry · 2009

DOI 10.1373/clinchem.2008.115352

narrative_reviewCited 181×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →